- Advertisement -
Shares in Mayne Pharma (ASX: MYX) have held steady this morning after the Adelaide-based company asserted its plans to terminate a $672 million acquisition deal with US giant Cosette Pharmaceuticals, alleging its erstwhile suitor committed material breaches of their takeover agreement.

